Front Row Advisors LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 283 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$5,952
-6.8%
4600.0%0.00%0.0%
Q1 2024$6,389
+208.8%
460
+217.2%
0.00%
+100.0%
Q4 2023$2,069
-70.9%
145
-68.5%
0.00%
-66.7%
Q3 2023$7,116
+101557.1%
4600.0%0.00%0.0%
Q2 2023$7
-12.5%
4600.0%0.00%
-25.0%
Q1 2023$8
+60.0%
460
+46.0%
0.00%
+33.3%
Q4 2022$5
-99.9%
315
-31.5%
0.00%0.0%
Q3 2022$6,0000.0%4600.0%0.00%0.0%
Q2 2022$6,000
-14.3%
4600.0%0.00%0.0%
Q1 2022$7,000
+16.7%
4600.0%0.00%
+50.0%
Q4 2021$6,000
-25.0%
4600.0%0.00%
-33.3%
Q3 2021$8,0000.0%4600.0%0.00%0.0%
Q2 2021$8,000
-63.6%
460
-62.5%
0.00%
-72.7%
Q1 2021$22,0000.0%1,2270.0%0.01%0.0%
Q4 2020$22,0000.0%1,2270.0%0.01%
-8.3%
Q3 2020$22,000
-15.4%
1,227
-13.8%
0.01%
-25.0%
Q2 2020$26,0000.0%1,4230.0%0.02%
-11.1%
Q1 2020$26,000
+4.0%
1,423
+10.4%
0.02%
+12.5%
Q4 2019$25,000
+13.6%
1,2890.0%0.02%0.0%
Q3 2019$22,000
-8.3%
1,289
-3.3%
0.02%
-5.9%
Q2 2019$24,000
+9.1%
1,333
+23.7%
0.02%0.0%
Q1 2019$22,0001,0780.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders